$SBFM
Sunshine Biopharma Inc.

2024 Q4 Form 10-Q Financial Statement

#000168316824007622 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $8.435M
YoY Change 41.59%
Cost Of Revenue $5.569M
YoY Change 40.37%
Gross Profit $2.866M
YoY Change 44.01%
Gross Profit Margin 33.98%
Selling, General & Admin $4.255M
YoY Change 41.29%
% of Gross Profit 148.47%
Research & Development $126.4K
YoY Change -46.91%
% of Gross Profit 4.41%
Depreciation & Amortization $64.63K
YoY Change 73.68%
% of Gross Profit 2.25%
Operating Expenses $4.382M
YoY Change 34.83%
Operating Profit -$1.106M
YoY Change 41.94%
Interest Expense $123.8K
YoY Change 221.26%
% of Operating Profit
Other Income/Expense, Net $123.8K
YoY Change -26.74%
Pretax Income -$982.6K
YoY Change 60.94%
Income Tax $215.2K
% Of Pretax Income
Net Earnings -$1.198M
YoY Change 83.86%
Net Earnings / Revenue -14.2%
Basic Earnings Per Share -$0.94
Diluted Earnings Per Share -$0.95
COMMON SHARES
Basic Shares Outstanding 2.000M shares 1.124M shares
Diluted Shares Outstanding 1.268M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.21M
YoY Change -35.24%
Cash & Equivalents $12.21M
Short-Term Investments
Other Short-Term Assets $735.8K
YoY Change 1739.5%
Inventory $9.821M
Prepaid Expenses $735.8K
Receivables $3.219M
Other Receivables $0.00
Total Short-Term Assets $25.98M
YoY Change 2.15%
LONG-TERM ASSETS
Property, Plant & Equipment $590.8K
YoY Change 76.4%
Goodwill
YoY Change
Intangibles $2.943M
YoY Change 141.96%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.075M
YoY Change 83.94%
TOTAL ASSETS
Total Short-Term Assets $25.98M
Total Long-Term Assets $4.075M
Total Assets $30.06M
YoY Change 8.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.157M
YoY Change 87.19%
Accrued Expenses $116.3K
YoY Change -3.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.528M
YoY Change -11.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $440.3K
YoY Change -21.38%
Total Long-Term Liabilities $489.0K
YoY Change -18.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.528M
Total Long-Term Liabilities $489.0K
Total Liabilities $5.018M
YoY Change -11.77%
SHAREHOLDERS EQUITY
Retained Earnings -$66.88M
YoY Change 6.74%
Common Stock $2.000K
YoY Change -92.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.04M
YoY Change
Total Liabilities & Shareholders Equity $30.06M
YoY Change 8.7%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.198M
YoY Change 83.86%
Depreciation, Depletion And Amortization $64.63K
YoY Change 73.68%
Cash From Operating Activities -$1.361M
YoY Change 195.86%
INVESTING ACTIVITIES
Capital Expenditures $609.5K
YoY Change 5995.2%
Acquisitions
YoY Change
Other Investing Activities $31.15K
YoY Change 3.83%
Cash From Investing Activities -$578.4K
YoY Change -2991.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.866M
YoY Change -3209.92%
NET CHANGE
Cash From Operating Activities -1.361M
Cash From Investing Activities -578.4K
Cash From Financing Activities 1.866M
Net Change In Cash -73.38K
YoY Change -85.32%
FREE CASH FLOW
Cash From Operating Activities -$1.361M
Capital Expenditures $609.5K
Free Cash Flow -$1.970M
YoY Change 319.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14012 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14012 shares
us-gaap Cost Of Revenue
CostOfRevenue
10641461 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2866151 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1990256 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001402328
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41282
dei Entity Registrant Name
EntityRegistrantName
SUNSHINE BIOPHARMA INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5566275
dei Entity Address Address Line1
EntityAddressAddressLine1
333 Las Olas Way
dei Entity Address Address Line2
EntityAddressAddressLine2
CU4 Suite 433
dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Lauderdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33301
dei Local Phone Number
LocalPhoneNumber
330-0684
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12206655 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3218682 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
9820730 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
735796 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
25981863 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
590801 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2942684 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
541468 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
4074953 usd
CY2024Q3 us-gaap Assets
Assets
30056816 usd
CY2024Q3 SBFM Earnout Payable
EarnoutPayable
0 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
254971 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
116253 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4528477 usd
CY2024Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
48729 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
440298 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
489027 usd
CY2024Q3 us-gaap Liabilities
Liabilities
5017504 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
13000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91737284 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
168590 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66881562 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
25039312 usd
CY2024Q3 us-gaap Revenues
Revenues
8435178 usd
CY2023Q3 us-gaap Revenues
Revenues
5957668 usd
us-gaap Revenues
Revenues
25279291 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
5569027 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
3967412 usd
us-gaap Cost Of Revenue
CostOfRevenue
17702546 usd
us-gaap Gross Profit
GrossProfit
7576745 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
124772 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
56350 usd
CY2024Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
100000 usd
CY2023Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
100000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
300000 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
118311 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
133302 usd
us-gaap Legal Fees
LegalFees
563745 usd
CY2024Q3 us-gaap Marketing Expense
MarketingExpense
282745 usd
CY2023Q3 us-gaap Marketing Expense
MarketingExpense
241897 usd
us-gaap Marketing Expense
MarketingExpense
737116 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126362 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
238012 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
784630 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
1144377 usd
us-gaap Salaries And Wages
SalariesAndWages
5183738 usd
CY2024Q3 us-gaap Depreciation
Depreciation
64627 usd
CY2023Q3 us-gaap Depreciation
Depreciation
37210 usd
us-gaap Depreciation
Depreciation
158115 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3972504 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2769730 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11351144 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1106353 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-779474 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3774399 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
15153 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
40 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
295921 usd
CY2024Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
108614 usd
CY2023Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
207431 usd
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
396698 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
245 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
123767 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
168944 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
692374 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-982586 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-610530 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3082025 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
215217 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40952 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-106121 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1197803 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-651482 usd
us-gaap Net Income Loss
NetIncomeLoss
-2975904 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
851640 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-460507 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-527515 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-346163 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1111989 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3503419 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-50.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-265.71
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218634 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1940610 usd
dei City Area Code
CityAreaCode
954
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1999660 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16292347 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2552362 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5734755 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
310591 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
24890055 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
365868 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1444259 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
646779 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2456906 usd
CY2023Q4 us-gaap Assets
Assets
27346961 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4157253 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2585466 usd
CY2023Q4 SBFM Earnout Payable
EarnoutPayable
2547831 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
299869 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118670 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5551836 usd
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
48729 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
539035 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
587764 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6139600 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1999660 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1999660 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
14 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84415900 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
696105 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63905658 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
21207361 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30056816 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27346961 usd
us-gaap Revenues
Revenues
16412586 usd
us-gaap Gross Profit
GrossProfit
5771125 usd
us-gaap Professional Fees
ProfessionalFees
565172 usd
us-gaap Professional Fees
ProfessionalFees
301381 usd
CY2024Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
475032 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
221781 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
576481 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
745850 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
300000 usd
us-gaap Legal Fees
LegalFees
392874 usd
us-gaap Marketing Expense
MarketingExpense
502987 usd
CY2024Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
530334 usd
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
544215 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2203970 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1422058 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1039502 usd
CY2024Q3 us-gaap Salaries And Wages
SalariesAndWages
2093850 usd
us-gaap Salaries And Wages
SalariesAndWages
4344801 usd
CY2024Q3 SBFM Income Tax Expense
IncomeTaxExpense
56471 usd
CY2023Q3 SBFM Income Tax Expense
IncomeTaxExpense
52586 usd
SBFM Income Tax Expense
IncomeTaxExpense
278177 usd
SBFM Income Tax Expense
IncomeTaxExpense
212953 usd
us-gaap Depreciation
Depreciation
106797 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9369203 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3598078 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-206 usd
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
624361 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-0 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
38527 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
107198 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
516957 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3081121 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
174899 usd
us-gaap Net Income Loss
NetIncomeLoss
-3256020 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
42702 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3213318 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.61
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1267565 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12845 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12254 shares
us-gaap Net Income Loss
NetIncomeLoss
-2975904 usd
us-gaap Net Income Loss
NetIncomeLoss
-3256020 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
158128 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
106794 usd
us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-0 usd
us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
374 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
12000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1321173 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
118482 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4201955 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1221112 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-251391 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-247977 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2229074 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-587973 usd
SBFM Increase Decrease In Earnout Payable
IncreaseDecreaseInEarnoutPayable
-2547831 usd
SBFM Increase Decrease In Earnout Payable
IncreaseDecreaseInEarnoutPayable
-172076 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-727628 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1084169 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9123898 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6085435 usd
SBFM Reduction In Right Of Use Asset
ReductionInRightOfUseAsset
92231 usd
SBFM Reduction In Right Of Use Asset
ReductionInRightOfUseAsset
97498 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
327088 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19804 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1554455 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
464614 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1789312 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-386920 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8522411 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4089218 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1940610 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1156 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3139651 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
541143 usd
SBFM Payment For Lease Liability
PaymentForLeaseLiability
87852 usd
SBFM Payment For Lease Liability
PaymentForLeaseLiability
93125 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7235518 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3456106 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16292347 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21826437 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3677692 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3016249 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-408000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35952 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12206655 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18846140 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
956012 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
SBFM Stock Issued For Services
StockIssuedForServices
12000 usd
SBFM Stock Issued For Services
StockIssuedForServices
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23489865 usd
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1895610 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-346163 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
25039312 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23109793 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
34321 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1111989 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
21963483 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
21207361 usd
SBFM Preferred Stock Issued To Related Party
PreferredStockIssuedToRelatedParty
12000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8522411 usd
SBFM Repurchase Of Warrants
RepurchaseOfWarrants
3139651 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3503419 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
25039312 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21627570 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
541143 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4089218 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1156 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3213318 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
21963483 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-100
CY2024Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1444259 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
776856 usd
us-gaap Finite Lived Intangible Assets Period Increase Decrease
FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
1594373 usd
CY2023 us-gaap Finite Lived Intangible Assets Period Increase Decrease
FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
710372 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3038632 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1487228 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
95948 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42969 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2942684 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1444259 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
105462 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
105462 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
105462 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
71032 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
19621 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
2000000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1999660 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1999660 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14012 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14012 shares
us-gaap Dividends
Dividends
0 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1197803 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-651482 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1267565 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12845 shares
CY2024Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2023Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1267565 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12845 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-50.72
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
541468 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
116253 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
440298 usd
SBFM Lessee Operating Leases Remaining Lease Term
LesseeOperatingLeasesRemainingLeaseTerm
5 years 3 months
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
28418 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
116458 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
110305 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
103897 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
97861 usd
CY2024Q3 SBFM Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
99611 usd
CY2024Q3 us-gaap Officers Compensation
OfficersCompensation
240176 usd
CY2023Q3 us-gaap Officers Compensation
OfficersCompensation
245000 usd
us-gaap Officers Compensation
OfficersCompensation
1595711 usd
us-gaap Officers Compensation
OfficersCompensation
1290000 usd
CY2024Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
100000 usd
CY2023Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
100000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
300000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
300000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007622-index-headers.html Edgar Link pending
0001683168-24-007622-index.html Edgar Link pending
0001683168-24-007622.txt Edgar Link pending
0001683168-24-007622-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbfm-20240930.xsd Edgar Link pending
Show.js Edgar Link pending
sunshine_ex3101.htm Edgar Link pending
sunshine_ex3102.htm Edgar Link pending
sunshine_ex3201.htm Edgar Link pending
sunshine_i10q-093024.htm Edgar Link pending
sbfm-20240930_cal.xml Edgar Link unprocessable
sbfm-20240930_def.xml Edgar Link unprocessable
sbfm-20240930_lab.xml Edgar Link unprocessable
sbfm-20240930_pre.xml Edgar Link unprocessable
sunshine_i10q-093024_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable